Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05076266 · ClinicalTrials.gov registry record
COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) Participation
A clinical trial, sponsored by Eastern Cooperative Oncology Group.
- Terminated
- Registry status
- 14
- Enrollment target
NCT05076266 is a clinical trial that was terminated before completion, run by Eastern Cooperative Oncology Group. The registered enrollment target is 14 participants.
The verdict
NCT05076266 was terminated before completion, sponsored by Eastern Cooperative Oncology Group.
- TERMINATED
- Registry status
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to find out whether factors that lead Women of Color to decline participation in the breast cancer screening trial EA1151 (TMIST) differ from non-women of color.
Interventions
- OTHER Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2022-03-14 |
| Est. Completion | 2023-02-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05076266
The ClinicalTrials.gov registry entry for NCT05076266 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eastern Cooperative Oncology Group, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Questionnaire is the first listed.
NCT05076266 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05076266 about?
NCT05076266 is a clinical study titled "COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) Participation". The purpose of this study is to find out whether factors that lead Women of Color to decline participation in the breast cancer screening trial EA1151 (TMIST) differ from non-women of color.
What is the current status of trial NCT05076266?
This trial is currently terminated. The enrollment target is 14 participants. The study started on 2022-03-14. Estimated completion is 2023-02-03.
What interventions are being tested in trial NCT05076266?
The interventions under investigation include: Questionnaire (OTHER).
Who is sponsoring clinical trial NCT05076266?
This trial is sponsored by Eastern Cooperative Oncology Group, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.